Concepedia

Ellena Growcott

EG

Statistics

Publications

8

Citations

534

H-Index

8

Active since

2005

Affiliations

Novartis (United States)(Current)

Hammersmith Hospital

Imperial College London

Novartis (Switzerland)

Pfizer (United Kingdom)

Ellena Growcott is an author at Novartis (United States) specializing in pharmacology, medicine, and molecular pharmacology.

ORCID

Publications per year

2005–2019

8

Publications

8

Antiproliferative Effects of Phosphodiesterase Type 5 Inhibition in Human Pulmonary Artery Cells

John Wharton, Julian Strange, Gigi M. O. Møller et al. · American Journal of Respiratory and Critical Care Medicine · 2005 · 368 citations

, , +17

Phosphodiesterase type 4 expression and anti-proliferative effects in human pulmonary artery smooth muscle cells

Ellena Growcott, Karen G. Spink, Xiaohui Ren et al. · Respiratory Research · 2006 · 53 citations · Full text

, , +15

IID572: A New Potentially Best-In-Class β-Lactamase Inhibitor

Folkert Reck, Alun Bermingham, Johanne Blais et al. · ACS Infectious Diseases · 2019 · 26 citations · Full text

, , +17

Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells

O.F. Ali, Ellena Growcott, Ghazwan Butrous et al. · Respiratory Research · 2011 · 25 citations · Full text

, , +14

Characterisation of a refined rat model of respiratory infection with Pseudomonas aeruginosa and the effect of ciprofloxacin

Ellena Growcott, Alan Coulthard, Richard T. Amison et al. · Journal of Cystic Fibrosis · 2011 · 24 citations · Full text

, , +14

1–5 of 8